Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 540

1.

The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness.

Vargas T, Ahmed AO, Strauss GP, Brandes CM, Walker EF, Buchanan RW, Gold JM, Mittal VA.

Transl Psychiatry. 2019 Sep 16;9(1):229. doi: 10.1038/s41398-019-0563-x.

PMID:
31527596
2.

Trait emotional experience in individuals with schizophrenia and youth at clinical high risk for psychosis.

Yee CI, Strauss GP, Allen DN, Haase CM, Kimhy D, Mittal VA.

BJPsych Open. 2019 Sep 10;5(5):e78. doi: 10.1192/bjo.2019.64.

3.

Determinants of utilization of cryopreservation of germ cells in adolescent cancer patients in four European countries.

Balcerek M, Schilling R, Byrne J, Dirksen U, Cario H, Fernandez-Gonzalez MJ, Kepak T, Korte E, Kruseova J, Kunstreich M, Lackner H, Langer T, Sawicka-Zukowska M, Stefanowicz J, Strauß G, Borgmann-Staudt A; PanCareLIFE.

Eur J Pediatr. 2019 Sep 7. doi: 10.1007/s00431-019-03459-9. [Epub ahead of print]

PMID:
31493021
4.

Fertility knowledge and associated empowerment following an educational intervention for adolescent cancer patients.

Borgmann-Staudt A, Kunstreich M, Schilling R, Balcerek M, Dirksen U, Cario H, Kepakova K, Klco-Brosius S, Korte E, Kruseova J, Lackner H, Langer T, Katarzyna MR, Stefanowicz J, Strauß G, Byrne J; PanCareLIFE.

Psychooncology. 2019 Aug 23. doi: 10.1002/pon.5210. [Epub ahead of print]

PMID:
31442341
5.

Use of Targeted High-Throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder.

Andres O, König EM, Althaus K, Bakchoul T, Bugert P, Eber S, Knöfler R, Kunstmann E, Manukjan G, Meyer O, Strauß G, Streif W, Thiele T, Wiegering V, Klopocki E, Schulze H; THROMKIDplus Study Group of the Society of Paediatric Oncology Haematology (Gesellschaft für Pädiatrische Onkologie und Hämatologie, GPOH) and the Society of Thrombosis Haemostasis Research (Gesellschaft für Thrombose- und Hämostaseforschung, GTH) .

TH Open. 2018 Dec 30;2(4):e445-e454. doi: 10.1055/s-0038-1676813. eCollection 2018 Oct.

6.

Immunostimulatory functions of adoptively transferred MDSCs in experimental blunt chest trauma.

Kustermann M, Klingspor M, Huber-Lang M, Debatin KM, Strauss G.

Sci Rep. 2019 May 29;9(1):7992. doi: 10.1038/s41598-019-44419-5.

7.

Voice Handicap Index-18 as an Instrument for Assessing Subjective Voice Impairment Between Voice Pre- and Post-treatment.

Feige K, Strauss A, Strauss G.

J Voice. 2019 May 17. pii: S0892-1997(18)30526-5. doi: 10.1016/j.jvoice.2019.04.005. [Epub ahead of print]

PMID:
31104880
8.

The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report.

Lee MR, Wehring HJ, McMahon RP, Liu F, Linthicum J, Buchanan RW, Strauss GP, Rubin LH, Kelly DL.

J Psychiatr Brain Sci. 2019;4(1). pii: e190001. doi: 10.20900/jpbs.20190001. Epub 2019 Jan 9.

PMID:
31037274
9.

Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors.

Zhang AY, Ganocy S, Fu AZ, Kresevic D, Ponsky L, Strauss G, Bodner DR, Zhu H.

Support Care Cancer. 2019 Mar 22. doi: 10.1007/s00520-019-04745-w. [Epub ahead of print]

PMID:
30903368
10.

Effort-based decision-making impairment in patients with clinically-stabilized first-episode psychosis and its relationship with amotivation and psychosocial functioning.

Chang WC, Chu AOK, Treadway MT, Strauss GP, Chan SKW, Lee EHM, Hui CLM, Suen YN, Chen EYH.

Eur Neuropsychopharmacol. 2019 May;29(5):629-642. doi: 10.1016/j.euroneuro.2019.03.006. Epub 2019 Mar 15.

PMID:
30879927
11.

Alterations in facial expressivity in youth at clinical high-risk for psychosis.

Gupta T, Haase CM, Strauss GP, Cohen AS, Mittal VA.

J Abnorm Psychol. 2019 May;128(4):341-351. doi: 10.1037/abn0000413. Epub 2019 Mar 14.

PMID:
30869926
12.

Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia.

Strauss GP, Chapman HC, Keller WR, Koenig JI, Gold JM, Carpenter WT, Buchanan RW.

J Psychiatr Res. 2019 May;112:38-43. doi: 10.1016/j.jpsychires.2019.02.017. Epub 2019 Feb 25.

PMID:
30849617
13.

A comprehensive review of psychophysiological applications for ecological momentary assessment in psychiatric populations.

Raugh IM, Chapman HC, Bartolomeo LA, Gonzalez C, Strauss GP.

Psychol Assess. 2019 Mar;31(3):304-317. doi: 10.1037/pas0000651. Review.

PMID:
30802116
14.

Emotion regulation across the psychosis continuum.

Chapman HC, Visser KF, Mittal VA, Gibb BE, Coles ME, Strauss GP.

Dev Psychopathol. 2019 Feb 11:1-9. doi: 10.1017/S0954579418001682. [Epub ahead of print]

PMID:
30739633
15.

Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.

Strauss GP, Esfahlani FZ, Kirkpatrick B, Allen DN, Gold JM, Visser KF, Sayama H.

Schizophr Bull. 2019 Jan 14. doi: 10.1093/schbul/sby168. [Epub ahead of print]

PMID:
30649527
16.

Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy.

Kühl JS, Kupper J, Baqué H, Ebell W, Gärtner J, Korenke C, Spors B, Steffen IG, Strauss G, Voigt S, Weschke B, Weddige A, Köhler W, Steinfeld R.

JAMA Netw Open. 2018 Jul 6;1(3):e180769. doi: 10.1001/jamanetworkopen.2018.0769.

17.

Using biobehavioral technologies to effectively advance research on negative symptoms.

Cohen AS, Schwartz E, Le TP, Fedechko T, Kirkpatrick B, Strauss GP.

World Psychiatry. 2019 Feb;18(1):103-104. doi: 10.1002/wps.20593. No abstract available.

18.

Disruptions in the Amount and Timing of Sleep and Repetitive Negative Thinking in Adolescents.

Stewart E, Gibb B, Strauss G, Coles M.

Behav Sleep Med. 2018 Dec 17:1-9. doi: 10.1080/15402002.2018.1557188. [Epub ahead of print]

PMID:
30557056
19.

Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains.

Strauss GP, Ahmed AO, Young JW, Kirkpatrick B.

Schizophr Bull. 2019 Jun 18;45(4):725-729. doi: 10.1093/schbul/sby169. No abstract available.

PMID:
30541136
20.

Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.

Azis M, Strauss GP, Walker E, Revelle W, Zinbarg R, Mittal V.

Schizophr Bull. 2019 Sep 11;45(5):1042-1050. doi: 10.1093/schbul/sby177.

PMID:
30535399
21.

Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents.

Verdú-Amorós J, Woessmann W, Maecker-Kolhoff B, Schulz A, Strauss G, Bein G, Hackstein H.

Transfusion. 2018 Nov;58(11):2495-2500. doi: 10.1111/trf.14880. Epub 2018 Oct 6.

PMID:
30291766
22.

Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.

Strauss GP, Esfahlani FZ, Galderisi S, Mucci A, Rossi A, Bucci P, Rocca P, Maj M, Kirkpatrick B, Ruiz I, Sayama H.

Schizophr Bull. 2019 Sep 11;45(5):1033-1041. doi: 10.1093/schbul/sby133.

PMID:
30256991
23.

The Latent Structure of Negative Symptoms in Schizophrenia.

Strauss GP, Nuñez A, Ahmed AO, Barchard KA, Granholm E, Kirkpatrick B, Gold JM, Allen DN.

JAMA Psychiatry. 2018 Dec 1;75(12):1271-1279. doi: 10.1001/jamapsychiatry.2018.2475.

24.

Apparent Diffusion Coefficient Levels and Neurodevelopmental Outcome in Fetuses with Brain MR Imaging White Matter Hyperintense Signal.

Katorza E, Strauss G, Cohen R, Berkenstadt M, Hoffmann C, Achiron R, Barzilay E, Bar-Yosef O.

AJNR Am J Neuroradiol. 2018 Oct;39(10):1926-1931. doi: 10.3174/ajnr.A5802. Epub 2018 Sep 6.

PMID:
30190257
25.

The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.

Strauss GP, Granholm E, Holden JL, Ruiz I, Gold JM, Kelly DL, Buchanan RW.

Psychol Med. 2019 Jul;49(10):1731-1739. doi: 10.1017/S0033291718002465. Epub 2018 Sep 5.

PMID:
30180918
26.

Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms.

Li Y, Li WX, Zou YM, Yang ZY, Xie DJ, Yang Y, Lui SSY, Strauss GP, Cheung EFC, Chan RCK.

Schizophr Res. 2018 Dec;202:248-253. doi: 10.1016/j.schres.2018.07.005. Epub 2018 Jul 8.

PMID:
29996973
27.

Altered selection during language processing in individuals at high risk for psychosis.

Vargas T, Snyder H, Banich M, Newberry R, Shankman SA, Strauss GP, Mittal VA.

Schizophr Res. 2018 Dec;202:303-309. doi: 10.1016/j.schres.2018.06.036. Epub 2018 Jun 20.

PMID:
29934248
28.

Diminished Hedonic response in neuroleptic-free youth at ultra high-risk for psychosis.

Strauss GP, Ruiz I, Visser KH, Crespo LP, Dickinson EK.

Schizophr Res Cogn. 2017 Dec 23;12:1-7. doi: 10.1016/j.scog.2017.12.001. eCollection 2018 Jun.

29.

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.

Suttorp M, Schulze P, Glauche I, Göhring G, von Neuhoff N, Metzler M, Sedlacek P, de Bont ESJM, Balduzzi A, Lausen B, Aleinikova O, Sufliarska S, Henze G, Strauss G, Eggert A, Kremens B, Groll AH, Berthold F, Klein C, Groß-Wieltsch U, Sykora KW, Borkhardt A, Kulozik AE, Schrappe M, Nowasz C, Krumbholz M, Tauer JT, Claviez A, Harbott J, Kreipe HH, Schlegelberger B, Thiede C.

Leukemia. 2018 Jul;32(7):1657-1669. doi: 10.1038/s41375-018-0179-9. Epub 2018 Jun 20.

PMID:
29925908
30.

Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.

Ahmed AO, Kirkpatrick B, Galderisi S, Mucci A, Rossi A, Bertolino A, Rocca P, Maj M, Kaiser S, Bischof M, Hartmann-Riemer MN, Kirschner M, Schneider K, Garcia-Portilla MP, Mane A, Bernardo M, Fernandez-Egea E, Jiefeng C, Jing Y, Shuping T, Gold JM, Allen DN, Strauss GP.

Schizophr Bull. 2019 Mar 7;45(2):305-314. doi: 10.1093/schbul/sby050.

PMID:
29912473
31.

The schizophrenia spectrum anhedonia paradox.

Strauss GP, Cohen AS.

World Psychiatry. 2018 Jun;17(2):221-222. doi: 10.1002/wps.20529. No abstract available.

32.

Low-pleasure beliefs in patients with schizophrenia and individuals with social anhedonia.

Yang Y, Yang ZY, Zou YM, Shi HS, Wang Y, Xie DJ, Zhang RT, Lui SSY, Cohen AC, Strauss GP, Cheung EFC, Chan RCK.

Schizophr Res. 2018 Nov;201:137-144. doi: 10.1016/j.schres.2018.05.018. Epub 2018 May 25.

PMID:
29804927
33.

Oxytocin and sexual function in males and females with schizophrenia.

Wehring HJ, Buchanan RW, Feldman S, Carpenter WT, McMahon RP, Weiner E, Gold JM, Adams HA, Strauss GP, Rubin LH, Kelly DL.

Schizophr Res. 2018 Sep;199:431-432. doi: 10.1016/j.schres.2018.03.013. Epub 2018 Mar 15. No abstract available.

PMID:
29551232
34.

TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.

Goldsmith DR, Haroon E, Miller AH, Strauss GP, Buckley PF, Miller BJ.

Schizophr Res. 2018 Sep;199:281-284. doi: 10.1016/j.schres.2018.02.048. Epub 2018 Feb 28.

35.

Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia.

Strauss GP, Visser KF, Keller WR, Gold JM, Buchanan RW.

Schizophr Res. 2018 Jul;197:156-161. doi: 10.1016/j.schres.2018.02.016. Epub 2018 Feb 27.

PMID:
29499966
36.

Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma.

Kaiser K, Prystaz K, Vikman A, Haffner-Luntzer M, Bergdolt S, Strauss G, Waetzig GH, Rose-John S, Ignatius A.

Naunyn Schmiedebergs Arch Pharmacol. 2018 May;391(5):523-536. doi: 10.1007/s00210-018-1483-7. Epub 2018 Mar 1.

37.

Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis.

Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, Rossi A, Bertolino A, Strauss GP, Aguglia E, Bellomo A, Murri MB, Bucci P, Carpiniello B, Comparelli A, Cuomo A, De Berardis D, Dell'Osso L, Di Fabio F, Gelao B, Marchesi C, Monteleone P, Montemagni C, Orsenigo G, Pacitti F, Roncone R, Santonastaso P, Siracusano A, Vignapiano A, Vita A, Zeppegno P, Maj M; Italian Network for Research on Psychoses.

JAMA Psychiatry. 2018 Apr 1;75(4):396-404. doi: 10.1001/jamapsychiatry.2017.4607.

38.

Sensitivity of the Positive and Negative Syndrome Scale (PANSS) in Detecting Treatment Effects via Network Analysis.

Esfahlani FZ, Sayama H, Visser KF, Strauss GP.

Innov Clin Neurosci. 2017 Dec 1;14(11-12):59-67.

39.

An ecological momentary assessment evaluation of emotion regulation abnormalities in schizophrenia.

Visser KF, Esfahlani FZ, Sayama H, Strauss GP.

Psychol Med. 2018 Oct;48(14):2337-2345. doi: 10.1017/S0033291717003865. Epub 2018 Jan 24.

PMID:
29361997
40.

Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis.

Schleker T, Jacobsen EM, Mayer B, Strauss G, Debatin KM, Posovszky C.

Mol Cell Pediatr. 2018 Jan 19;5(1):1. doi: 10.1186/s40348-018-0079-0.

41.

The brief negative symptom scale (BNSS): Sensitivity to treatment effects.

Kirkpatrick B, Saoud JB, Strauss GP, Ahmed AO, Tatsumi K, Opler M, Luthringer R, Davidson M.

Schizophr Res. 2018 Jul;197:269-273. doi: 10.1016/j.schres.2017.11.031. Epub 2017 Dec 21.

PMID:
29275856
42.

Diagnosis of platelet function disorders: A standardized, rational, and modular flow cytometric approach.

Andres O, Henning K, Strauß G, Pflug A, Manukjan G, Schulze H.

Platelets. 2018 Jun;29(4):347-356. doi: 10.1080/09537104.2017.1386297. Epub 2017 Dec 11.

PMID:
29227167
43.

A need for standardization in visual acuity measurement.

Patel H, Congdon N, Strauss G, Lansingh C.

Arq Bras Oftalmol. 2017 Sep-Oct;80(5):332-337. doi: 10.5935/0004-2749.20170082. Review.

44.

Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups.

Ahmed AO, Strauss GP, Buchanan RW, Kirkpatrick B, Carpenter WT.

J Psychiatr Res. 2018 Feb;97:8-15. doi: 10.1016/j.jpsychires.2017.11.004. Epub 2017 Nov 12.

PMID:
29156414
45.

Splenic glucocorticoid resistance following psychosocial stress requires physical injury.

Foertsch S, Füchsl AM, Faller SD, Hölzer H, Langgartner D, Messmann J, Strauß G, Reber SO.

Sci Rep. 2017 Nov 16;7(1):15730. doi: 10.1038/s41598-017-15897-2.

46.

Distinct Effects of IL-6 Classic and Trans-Signaling in Bone Fracture Healing.

Prystaz K, Kaiser K, Kovtun A, Haffner-Luntzer M, Fischer V, Rapp AE, Liedert A, Strauss G, Waetzig GH, Rose-John S, Ignatius A.

Am J Pathol. 2018 Feb;188(2):474-490. doi: 10.1016/j.ajpath.2017.10.011. Epub 2017 Nov 13.

47.

MDSCs are induced after experimental blunt chest trauma and subsequently alter antigen-specific T cell responses.

Hüsecken Y, Muche S, Kustermann M, Klingspor M, Palmer A, Braumüller S, Huber-Lang M, Debatin KM, Strauss G.

Sci Rep. 2017 Oct 9;7(1):12808. doi: 10.1038/s41598-017-13019-6.

48.

A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Strauss GP, Cohen AS.

Schizophr Bull. 2017 Jul 1;43(4):712-719. doi: 10.1093/schbul/sbx066. Review.

49.

Bullying victimization and perpetration in a community sample of youth with psychotic like experiences.

Strauss GP, Raugh IM, Mittal VA, Gibb BE, Coles ME.

Schizophr Res. 2018 May;195:534-536. doi: 10.1016/j.schres.2017.08.056. Epub 2017 Sep 6.

PMID:
28888357
50.

Impact of genetic variants on haematopoiesis in patients with thrombocytopenia absent radii (TAR) syndrome.

Manukjan G, Bösing H, Schmugge M, Strauß G, Schulze H.

Br J Haematol. 2017 Nov;179(4):606-617. doi: 10.1111/bjh.14913. Epub 2017 Aug 31.

PMID:
28857120

Supplemental Content

Loading ...
Support Center